Cell Signaling Technology

Product Pathways - Growth Factors/Cytokines

Human Neuregulin-1 (hNRG-1) #5218

heregulin   neuregulin   NGR1  

No. Size Price
5218SC 50 µg ( With Carrier ) ¥2,580.00 现货查询 购买询价
5218SF 50 µg ( Carrier Free ) ¥2,580.00 现货查询 购买询价
5218 carrier free & custom formulation / quantityemail request
Applications Dilution Species-Reactivity Sensitivity MW (kDa) Isotype

Species cross-reactivity is determined by western blot.

Applications Key:

Source / Purification

Recombinant human NRG-1 (hNRG-1) Thr176-Lys238 (Accession #NP_001153480) was produced in E. coli cells at Cell Signaling Technology.

CST公司在大肠杆菌中生产重组人源蛋白NRG-1 (hNRG-1) Thr176-Lys238 (Accession #NP_001153480)。

Molecular Characterization

Recombinant hNRG-1 does not have a Met on the amino terminus and has a calculated MW of 7,415. DTT-reduced and non-reduced protein migrate as 6 kDa polypeptides. The expected amino-terminal TSHLV of recombinant hNRG-1 was verified by amino acid sequencing.

重组的hNRG-1蛋白在N-末端没有Met,其分子量据推算为7,415Da。DTT-还原和未还原的蛋白迁移时是作为一个6 kDa 的多肽而转移。重组hNRG-1蛋白的N-末端TSHLV的序列通过测序得到。

Purity

>98% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant hNRG-1. All lots are greater than 98% pure.

6 μg 还原 (+) 和 非还原的(-) hNRG-1通过SDS-PAGE检测,纯度大于98%,所有批次的纯度均高于98%。

Bioactivity

The bioactivity of recombinant hNRG-1 was determined in a cell proliferation assay using MCF7 cells. The ED50 of each lot is between 1-4 ng/ml.

重组蛋白hNRG-1的生物活性是同过MCF7细胞的细胞增殖实验确定的。每个批次的ED50在1-4 ng/ml之间。

Coomassie Gel

Coomassie Gel

The purity of recombinant hNRG-1 was determined by SDS-PAGE of 6 µg reduced (+) and non-reduced (-) recombinant hNRG-1 and staining overnight with Coomassie Blue.重组蛋白hNRG-1的纯度用6 µg还原(+) 和未还原(-)的蛋白走SDS-PAGE 胶来观察。考马斯亮蓝染色过夜。

Bioactivity

Bioactivity

The proliferation of MCF7 cells treated with increasing concentrations of hNRG-1 was assessed. After a 7 day treatment with hNRG-1 cells were incubated with a tetrazolium salt and the OD450 - OD650 was determined.用递增浓度hNRG-1处理MCF7细胞。经过hNRG-1处理7天后在四唑盐中孵育,并测定OD450- OD650 的数值。

Western Blotting

Western Blotting

Western blot analysis of extracts from MCF7 cells, untreated or treated with hNRG-1 for 7 minutes, using Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP® Rabbit mAb #4370 (upper) and p44/42 MAPK (Erk1/2) (137F5) Rabbit mAb #4695 (lower).Western免疫印迹。用Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP® Rabbit mAb #4370 (上图)和p44/42 MAPK (Erk1/2) (137F5) Rabbit mAb #4695 (下图)研究未经处理和经hNRG-1 处理7分钟的MCF7细胞的细胞提取液。

Endotoxin

Less than 0.01 ng endotoxin/1 μg hNRG-1.

内毒素含量:<0.01 ng /1 μg hNRG-1。

Formulation

With carrier: Lyophilized from a 0.22 μm filtered solution of 20 mM citrate, pH 3.0 containing 100 mM NaCl and 20 μg BSA per 1 μg hNRG-1. Carrier free: Lyophilized from a 0.22 μm filtered solution of 20 mM citrate, pH 3.0 containing 100 mM NaCl.

有载体: 每微克hNRG-1蛋白溶解在包含 20 μg BSA的20 mM 柠檬酸盐(pH 3.0)溶液中,并通过 0.22 μm 滤膜冻干。

无载体:每微克hNRG-1蛋白溶解在20 mM 柠檬酸盐(pH 3.0)溶液中,并通过 0.22 μm 滤膜冻干。

Background

NRG-1, a member of the EGF family, is involved in heart, mammary and nervous system development (1). NRG-1 is expressed by mammary epithelial, vascular endothelial and neuronal cells (2,3). At least 15 NRG-1 splice variants are known (1). These variants differ in EGF domains (α or β variants), amino-terminal splicing sites, and incorporation of exons encoding integral membrane regions (1). NRG-1 can induce or inhibit the proliferation of cells derived from breast cancer. The differences in effects of NRG-1 appear to depend on splice variation and interaction with receptor(s) (2). NRG-1 binds to ErbB3/HER3 or ErbB4/HER4. Binding induces dimerization with ErB2/HER2. The Akt, Erk1/2 and Erk5 pathways have been shown to participate in NRG-1 activated signaling (4,5). NRG-1 appears to have roles in schizophrenia and breast cancer (1,4,6).

NRG-1是EGF家族成员之一, 它参与了心脏、乳腺和神经系统的发育(1)。NRG-1是通过乳腺上皮细胞、血管内皮细胞核神经元细胞表达 (2,3)。至少有15种 NRG-1可变剪切是已知的(1)。这些不同的剪切形式差别主要是在EGF域(α或 β形式)、N-末端的可变剪切位点和结合外显子编码整合膜域(1)。NRG-1能够抑制乳腺癌起源细胞的增殖。NRG-1不同的作用可能依赖于不同的剪切形式以及与受体的相互作用(2)。NRG-1结合到ErbB3/HER3或者ErbB4/HER4。结合又诱导了与 ErB2/HER2的二聚化。Akt, Erk1/2和Erk5 通路也参与到了NRG-1激活的信号过程中(4,5)。NRG-1可能对精神分裂症和乳腺癌中也有作用(1,4,6)。

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products


For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.

用户评论 --- 共 0

该产品暂无评论!

我要参与评论 :

如要参与评论请先登录网站

还没有网站账户?去注册一下吧

Products

 

Applications